N Zaffaroni Selected Research

N Zaffaroni Research Topics

Disease

20	Neoplasms (Cancer) 06/2014 - 02/2000
6	Melanoma (Melanoma, Malignant) 09/2002 - 02/2000
5	Ovarian Neoplasms (Ovarian Cancer) 08/2002 - 05/2000
4	Carcinoma (Carcinomatosis) 07/2004 - 05/2000
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2014 - 09/2002
3	Liposarcoma 10/2009 - 03/2008
2	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 05/2013
2	Disease Progression 01/2017 - 06/2014
2	Carcinogenesis 01/2013 - 01/2005
2	Breast Neoplasms (Breast Cancer) 03/2009 - 01/2001
2	Prostatic Neoplasms (Prostate Cancer) 12/2007 - 07/2004
2	Osteosarcoma (Osteogenic Sarcoma) 09/2002 - 10/2001
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2017
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 11/2014
1	Solitary Fibrous Tumors 09/2013
1	Hypoglycemia (Reactive Hypoglycemia) 09/2013
1	Paraganglioma (Paragangliomas) 06/2013
1	Pheochromocytoma 06/2013
1	Ewing Sarcoma (Sarcoma, Ewing) 05/2013
1	Poisoning 01/2013
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2012
1	Neutropenia 01/2012
1	Endometrial Neoplasms (Endometrial Cancer) 01/2012
1	Alveolar Soft Part Sarcoma 07/2011
1	Mesothelioma 07/2003
1	Papillary Thyroid Cancer 07/2003

Drug/Important Bio-Agent (IBA)

14	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2009 - 02/2000
7	EnzymesIBA 05/2013 - 06/2001
5	Cisplatin (Platino)FDA LinkGeneric 03/2014 - 03/2001
4	pazopanib FDA Link 01/2017 - 09/2013
4	PlatinumIBA 03/2014 - 03/2001
4	Pharmaceutical PreparationsIBA 03/2014 - 09/2002
4	Catalytic RNA (Ribozymes)IBA 02/2003 - 02/2000
3	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 05/2000
3	Sunitinib (Sutent)FDA Link 11/2014 - 07/2011
3	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2013 - 01/2012
3	Proteins (Proteins, Gene)FDA Link 03/2009 - 06/2001
3	Cell ExtractsIBA 09/2002 - 02/2000
2	Bevacizumab (Avastin)FDA Link 11/2014 - 09/2013
2	Angiogenesis InhibitorsIBA 06/2014 - 05/2013
2	telomerase RNA (bTR)IBA 04/2008 - 06/2001
2	Messenger RNA (mRNA)IBA 12/2007 - 06/2001
2	Cell-Penetrating PeptidesIBA 12/2007 - 05/2000
2	Nucleic AcidsIBA 12/2007 - 05/2000
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2001 - 02/2000
2	BBR 3464 (BBR3464)IBA 05/2001 - 03/2001
2	hammerhead ribozymeIBA 10/2000 - 02/2000
2	RNA (Ribonucleic Acid)IBA 10/2000 - 02/2000
1	Sorafenib (BAY 43-9006)FDA Link 11/2014
1	regorafenibIBA 11/2014
1	Axitinib (AG 013736)IBA 11/2014
1	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2014
1	ascrinvacumabIBA 06/2014
1	Monoclonal AntibodiesIBA 06/2014
1	LigandsIBA 03/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2014
1	Adenosine Triphosphate (ATP)IBA 03/2014
1	Drug CombinationsIBA 03/2014
1	Interleukin-8 (Interleukin 8)IBA 01/2014
1	CytokinesIBA 01/2014
1	TriazinesIBA 09/2013
1	Temozolomide (Temodar)FDA LinkGeneric 09/2013
1	Dacarbazine (DIC)FDA LinkGeneric 09/2013
1	Heparin (Liquaemin)FDA LinkGeneric 05/2013
1	heparanaseIBA 05/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2013
1	SST 0001IBA 05/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2013
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 05/2013
1	AnticoagulantsIBA 05/2013
1	Conditioned Culture MediaIBA 05/2013
1	Tyrosine (L-Tyrosine)FDA Link 05/2013
1	A-Form DNA (A-DNA)IBA 01/2013
1	CamptothecinIBA 01/2013
1	MicroRNAs (MicroRNA)IBA 01/2013
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2012
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2012
1	LactonesIBA 01/2012
1	PoisonsIBA 01/2012
1	namitecanIBA 01/2012
1	Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA 01/2012
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 07/2011
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2011
1	Biological ProductsIBA 01/2011
1	Small Interfering RNA (siRNA)IBA 03/2009
1	Caspase 3 (Caspase-3)IBA 03/2009
1	ChromatinIBA 04/2008
1	ParaffinIBA 03/2008
1	Formaldehyde (Formol)FDA Link 03/2008
1	Peptides (Polypeptides)IBA 12/2007
1	OligonucleotidesIBA 01/2005
1	Phosphorothioate OligonucleotidesIBA 07/2004
1	RNA Precursors (Precursor, mRNA)IBA 07/2004
1	OxindolesIBA 07/2003
1	Oncogene Proteins (Oncogene Protein)IBA 07/2003

Therapy/Procedure

6	Therapeutics 03/2014 - 02/2000
3	Drug Therapy (Chemotherapy) 01/2017 - 06/2001
1	Aftercare (After-Treatment) 09/2013
1	Radiotherapy 06/2013
1	Hyperthermic Intraperitoneal Chemotherapy 07/2003